These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2405920)

  • 41. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system.
    Bataille R; Boccadoro M; Klein B; Durie B; Pileri A
    Blood; 1992 Aug; 80(3):733-7. PubMed ID: 1638024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma.
    Kim JE; Yoo C; Lee DH; Kim SW; Lee JS; Suh C
    Ann Hematol; 2010 Apr; 89(4):391-7. PubMed ID: 19844712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. International Staging System required standardization of biochemical laboratory testing in multiple myeloma.
    Tichý M; Maisnar V; Palicka V; Friedecký B; Vávrová J; Novotná H; Cermáková Z; Dastych M; Cechák P; Vogtová D; Jarolímková E; Benáková H; Hachová L; Bezdícková D; Kouril F; Zábranská EA; Zenková J; Slabý P; Scudla V; Gregora E; Spicka I; Straub J; Schützova M; Hájek R
    Neoplasma; 2006; 53(6):492-4. PubMed ID: 17167717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical features and survival of Chilean patients with multiple myeloma].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2007 Sep; 135(9):1111-7. PubMed ID: 18064364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum beta 2-microglobulin at remission and relapse in patients with multiple myeloma.
    Brenning G; Wibell L; Bergström R
    Eur J Clin Invest; 1985 Oct; 15(5):242-7. PubMed ID: 3935453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A study of the significance of serum beta 2-microglobulin levels in patients with multiple myeloma--analyzes as a marker of renal dysfunction and as a marker of tumor cell mass].
    Nishinarita S; Shimada H; Suzuki R; Kishigami Y; Sawada U; Horie T
    Rinsho Ketsueki; 1996 Mar; 37(3):201-7. PubMed ID: 8727343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic implications of myeloma staging.
    Durie BG; Bataille R
    Eur J Haematol Suppl; 1989; 51():111-6. PubMed ID: 2697583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis].
    Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
    Vnitr Lek; 1991 Apr; 37(4):342-51. PubMed ID: 2053304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
    Hillengass J; Wasser K; Delorme S; Kiessling F; Zechmann C; Benner A; Kauczor HU; Ho AD; Goldschmidt H; Moehler TM
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):475-81. PubMed ID: 17255268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group.
    Seidel C; Børset M; Turesson I; Abildgaard N; Sundan A; Waage A
    Blood; 1998 Feb; 91(3):806-12. PubMed ID: 9446640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.
    Palumbo A; Bringhen S; Falco P; Cavallo F; Ambrosini MT; Avonto I; Gay F; Caravita T; Bruno B; Boccadoro M
    Cancer; 2007 Aug; 110(4):824-9. PubMed ID: 17594696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
    Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of serum beta 2 microglobulin in primary gastric lymphoma.
    Avilés A; Díaz-Maqueo JC; Rodriguez L; García EL; Guzmán R; Talavera A
    Hematol Oncol; 1991; 9(2):115-21. PubMed ID: 1869242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Multiple myeloma with 5-year survival. Study of initial prognostic factors. Role of beta-2-microglobulin].
    Franco M; Fuzibet JG; Cassuto JP; Pesce A; Ziegler G; Dujardin P
    Rev Rhum Mal Osteoartic; 1985 Nov; 52(11):619-23. PubMed ID: 3909365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma.
    Kaiser U; Oldenburg M; Jaques G; Auerbach B; Havemann K
    Ann Hematol; 1996 Sep; 73(3):121-6. PubMed ID: 8841099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.
    Norfolk D; Child JA; Cooper EH; Kerruish S; Ward AM
    Br J Cancer; 1980 Oct; 42(4):510-5. PubMed ID: 6159910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic factors in multiple myeloma.
    Kyle RA
    Stem Cells; 1995 Aug; 13 Suppl 2():56-63. PubMed ID: 8520513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma].
    Kraj M; Maj S; Pogłód R; Rostkowska J
    Acta Haematol Pol; 1989; 20(2):140-51. PubMed ID: 2700533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone marrow histology and serum beta 2 microglobulin in multiple myeloma--a new prognostic strategy.
    Bartl R; Frisch B; Diem H; Mündel M; Fateh-Moghadam A
    Eur J Haematol Suppl; 1989; 51():88-98. PubMed ID: 2697597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.